Please use this identifier to cite or link to this item:
|Title:||建立知识经济时代的竞争优势 = Building the competitive advantage in the knowledge economy : an analysis of the added-value of the intellectual capital of Xian-Janssen from the knowledge management perspective||Authors:||李一敏 Li, Yimin||Keywords:||DRNTU::Business::Management::Intellectual capital||Issue Date:||2005||Abstract:||The reform and "Open Door Policy" in China have created the energetic growth of the Chinese pharmaceutical industry. Since 1980's, the top 50 pharmaceutical companies in the world have set up their joint ventures in China and have achieved remarkable success. These joint ventures have not only brought in the concept of "Good Manufacturing Practice (GMP)" and lots of patent drugs to the Chinese pharmaceutical market, but also the modern management concept and practice to the industry. "Xian-Janssen Pharmaceutical Ltd", as the No.1 leading pharmaceutical JV in China, is a successful model among all.||URI:||http://hdl.handle.net/10356/7521||Rights:||Nanyang Technological University||Fulltext Permission:||restricted||Fulltext Availability:||With Fulltext|
|Appears in Collections:||NBS Theses|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.